[A 2-year follow-up of lisinopril shows a positive profile concerning adverse effects].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects; D004656:Enalapril / Q000009:adverse effects / Q000031:analogs & derivatives*; D005500:Follow-Up Studies; D017706:Lisinopril
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004656:Enalapril; D017706:Lisinopril
Tvåårsuppföljning av lisinopril visar gynnsam biverkningsprofil.